Stock A195940 HK INNO.N CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages HK inno.N Corporation

Equities

A195940

KR7195940002

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
36,150 KRW -0.82% Intraday chart for HK inno.N Corporation -4.99% -18.67%
2022 Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights from HK inno.N Corporation to Develop and Commercialize Tegoprazan in the U.S. and Canada CI
2022 Sebela Pharmaceuticals Enters an Exclusive Partnership with HK inno.N Corporation CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights from HK inno.N Corporation to Develop and Commercialize Tegoprazan in the U.S. and Canada
Sebela Pharmaceuticals Enters an Exclusive Partnership with HK inno.N Corporation
Indian Indices Close in the Red Midweek; Shree Cement Slides 4%
Dr. Reddy's to Market HK inno.N's Gastrointestinal Diseases Drug in India, Emerging Markets
Dr. Reddy's Laboratories Ltd. Enters into an Exclusive Partnership with South Korea-Based HK Inno.N Corporation
HK inno.N Corporation announces an Equity Buyback for KRW 24,200 million worth of its shares.
HK inno.N Corporation authorizes a Buyback Plan.
Kolmar Korea to Acquire 40% Stake in Biotech Firm Next & Bio
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A195940 Stock
  4. News HK inno.N Corporation
  5. Other languages